SurvivorNet on MSNOpinion
A simpler delivery system: FDA approves subcutaneous injection version of powerful targeted drug isatuximab for multiple myeloma
A new under‑the‑skin version of isatuximab is now approved, giving multiple myeloma patients a much faster and more ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results